CLINTICAL STUDIES ON NEOCARZINOSTATIN IN THE FIELD OF UROLOGY FIRST REPORT; ABSORPTION INTO REGIONAL LYMPHNODE OF NCS BY INTRAVESICAL INSTILLATION by 桑原, 守正 et al.
Title泌尿器科領域におけるNeocarzinostatinに関する臨床的研究 第1報 : 膀胱内投与による所属リンパ節移行について
Author(s)桑原, 守正; 玉置, 俊晃; 米沢, 正隆; 今川, 章夫












桑  原  守  正
徳  置  俊  晃
米  沢  正  隆
今  川  章  夫
CLINTICAL STUDIES ON NEOCARZINOSTATIN
     IN THE FIELD OF UROLOGY
F工RST REPORT；ABSORPTION INTO REGIONAL LYMPHNODE
     OF NCS BY INTRAVESICAL INSTILLATION
      Morimasa KuwAHARA， Toshiaki TAMAKi，
      Masataka YoNEzAwA and Akio IMAGAwA
From the DePartmentげUrogogy， TakamatSU Redα0∬Hospital， Kagaωa，ノdPan
  Two million 1．U． of neocarzinostatin （NCS） was administered to 8 patients with bladder tumor
by intravesical instillation before operations． The concentration of each tissue （norrnal bladder，
bladder tumor and lymph nodes） and serum concentration were nieasured． The following results
was obtained．
1） NCS is absorbed into the normal bladder and bladder tumor by intravesical instillation．
2） Absorption into regional lymph nodes was partly noted．
3＞It is about two hQurs after intravesical instil工ation that NCS migrates tQwards the serum．
  These results suggest that chemotherapy for regional metastatic lymph nodes after TUR－Bt would
be possible by intravesical instillation of NCS．





















Brodersの分類4）でGrade I 1例， Grade II 3例，
Grade III 3例， Grade IV 1例であった．また進行
38 泌尿紀要 28巻 1号 1982年
Table 1． Patients instilled NCS into the urinary bladder
























































































Table 2． Concentration of Neocarzinostatin in serum and tissues （mcgfml， g）
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